Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed May 15, 2025 · 10-Q · 45 days after period end · 0001477932-25-003761
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$530.27K | -$376.33K | -$389.74K | -$2.80M |
| EPS Diluted | $0.00 | $0.00 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end
